Cargando…

Adherence to Guideline‐Recommended Therapy Is Associated With Decreased Major Adverse Cardiovascular Events and Major Adverse Limb Events Among Patients With Peripheral Arterial Disease

BACKGROUND: Current guidelines recommend that patients with peripheral arterial disease (PAD) cease smoking and be treated with aspirin, statin medications, and angiotensin‐converting enzyme (ACE) inhibitors. The combined effects of multiple guideline‐recommended therapies in patients with symptomat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Armstrong, Ehrin J., Chen, Debbie C., Westin, Gregory G., Singh, Satinder, McCoach, Caroline E., Bang, Heejung, Yeo, Khung‐Keong, Anderson, David, Amsterdam, Ezra A., Laird, John R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4187469/ https://www.ncbi.nlm.nih.gov/pubmed/24721799 http://dx.doi.org/10.1161/JAHA.113.000697

Ejemplares similares

Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
por: Armstrong, Ehrin J., et al.
Publicado: (2013)

Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease
por: Chen, Debbie C, et al.
Publicado: (2015)

Association of Lipoprotein(a) Levels With Incidence of Major Adverse Limb Events
por: Guédon, Alexis F., et al.
Publicado: (2022)

Xerosis and pruritus as major EGFRI-associated adverse events
por: Clabbers, Julia M. K., et al.
Publicado: (2015)

Predictors for the Development of Major Adverse Limb Events after Percutaneous Revascularization—Gender-Related Characteristics
por: Comsa, Horatiu, et al.
Publicado: (2023)

Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review
por: Biscetti, Federico, et al.
Publicado: (2021)

Sarcoidosis: comprehensive CMR evaluation and major adverse cardiac events
por: Higgins, Angela Y, et al.
Publicado: (2016)

Low Prevalance of Major Events Adverse to Exercise Stress Echocardiography
por: Andrade, Stephanie Macedo, et al.
Publicado: (2016)

Risk of Major Adverse Cardiovascular Events in Patients With Rheumatoid Arthritis
por: Mal, Kheraj, et al.
Publicado: (2020)

Prediabetes as a risk factor for major adverse cardiovascular events
por: Mando, Ramy, et al.
Publicado: (2021)

Association of Prior Intracerebral Hemorrhage With Major Adverse Cardiovascular Events
por: Gaist, David, et al.
Publicado: (2022)

Comparison of HEAR and HEART Scores for Major Adverse Cardiovascular Events
por: Uyan, Umut
Publicado: (2023)

Major adverse cardiovascular events and hyperuricemia during tuberculosis treatment
por: Shin, Hong-Joon, et al.
Publicado: (2023)

Associations of Modified Healthy Aging Index With Major Adverse Cardiac Events, Major Coronary Events, and Ischemic Heart Disease
por: Huang, Ninghao, et al.
Publicado: (2023)

Hospital Readmissions Following Endovascular Therapy for Critical Limb Ischemia: Associations With Wound Healing, Major Adverse Limb Events, and Mortality
por: Reed, Grant W., et al.
Publicado: (2016)

Impact of heart failure severity and major bleeding events after percutaneous coronary intervention on subsequent major adverse cardiac events
por: Ikebe, So, et al.
Publicado: (2023)

Adverse events and outcomes of procedural sedation and analgesia in major trauma patients
por: Green, Robert S., et al.
Publicado: (2015)

The burden of major adverse cardiac events in patients with coronary artery disease
por: Tsai, I-Ting, et al.
Publicado: (2017)

Impact of Discrepancies in General and Abdominal Obesity on Major Adverse Cardiac Events
por: Choi, Daein, et al.
Publicado: (2019)

Determinants of Major Adverse Kidney Events in Extracorporeal Membrane Oxygenation Survivors
por: Bobba, Aniesh, et al.
Publicado: (2022)

Postoperative Major Adverse Cardiac Events in Patients With Systemic Lupus Erythematosus
por: Bruera, Sebastian, et al.
Publicado: (2022)

Heterogeneous plaque–lumen geometry is associated with major adverse cardiovascular events
por: Gu, Sophie Z, et al.
Publicado: (2023)

The effect of deep vein thrombosis on major adverse limb events in diabetic patients: a nationwide retrospective cohort study
por: Wang, Po-Chang, et al.
Publicado: (2021)

Long‐Term Visit‐to‐Visit Glycemic Variability as a Predictor of Major Adverse Limb and Cardiovascular Events in Patients With Diabetes
por: Hsu, Jung‐Chi, et al.
Publicado: (2023)

Association of smoking with restenosis and major adverse cardiac events after coronary stenting: A meta-analysis
por: Hu, Rui-ting, et al.
Publicado: (2015)

Endothelial Dysfunction Is Associated With Major Adverse Cardiovascular Events in Peritoneal Dialysis Patients
por: Lee, Mi Jung, et al.
Publicado: (2014)

Safety analysis over time: seven major changes to adverse event investigation
por: Vincent, Charles, et al.
Publicado: (2017)

Major adverse cardiac events and drug-coated balloon size in coronary interventions
por: Naguib, David, et al.
Publicado: (2018)

Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients
por: Peluso, Rosario, et al.
Publicado: (2018)

Visfatin associated with major adverse cardiovascular events in patients with acute myocardial infarction
por: Zheng, Meifan, et al.
Publicado: (2020)

Genetic information improves the prediction of major adverse cardiovascular events in the GENEMACOR population
por: Mendonça, Maria Isabel, et al.
Publicado: (2021)

Impact of Clopidogrel Stop Interval on Major Adverse Bleeding Events in Cardiac Surgery
por: Huo, Bright, et al.
Publicado: (2021)

Cardiac rehabilitation performance predicts 1‐year major adverse cardiovascular events
por: Naami, Robert, et al.
Publicado: (2022)

Impact of Vaccination on Major Adverse Cardiovascular Events in Patients With COVID-19 Infection
por: Jiang, Joy, et al.
Publicado: (2023)

Necroptosis Drives Major Adverse Cardiovascular Events During Severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

Major adverse cardiovascular events are associated with necroptosis during severe COVID-19
por: Wiscovitch-Russo, Rosana, et al.
Publicado: (2023)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

IMPACT OF VACCINATION ON MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG PATIENTS WITH COVID-19
por: Jiang, Joy, et al.
Publicado: (2023)

Ten-year predictors of major adverse cardiovascular events in patients without angina
por: Premsagar, Preesha, et al.
Publicado: (2023)

Saddle embolism is associated with the major adverse events in patients with nonhigh-risk pulmonary embolism
por: Kim, H, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vj3nlifn4o3slcp4kqfqijh78j